India's vibrant Biotechnology sector ; A failsafe investment option

▴ India's vibrant Biotechnology sector ; A failsafe investment option
Under the current scenario, investing in Biotech stocks could get you lucrative returns

India is among the top 12 destinations for biotechnology in the world, with approximately 3% share in the global Biotechnology industry, poised for growth as a key contributor of India’s $5 tn economy target by FY 2024. India also plays a key role in the global vaccine market, as the leader in the global supply of DPT, BCG, and measles vaccines, and the contributor of 70% of WHO’s vaccines (essential Immunization Schedule). India ranks 48th on the Global Innovation Index.

India has the maximum no. of US FDA-approved manufacturing sites outside the US with 33% of total exports being supplied to the USA.

Salient Features of the Biotechnology sector

- By FY24, the Indian Biotechnology industry is expected to reach $150 bn from $62.5 bn in FY20
- By FY24, the contribution of the Indian biotechnology industry in the global biotechnology market is expected to grow to 19% from 3% in FY18
- By FY24, India is expected to have over 10,000 biotech startups from the 3,475 startups in FY21
- There are 600+ core biotech companies with 200+ Biotech products available in the Indian market
- There are 50 Bio-incubators with an approximate Incubation space of 5,49,000+ sq ft across India supporting 650+ Incubatees
- There are 9 Biotechnology Parks and 4 Biotechnology Science Clusters across India
- 100% FDI is allowed under the automatic route for greenfield pharma.

- 100% FDI is allowed under the government route for brownfield pharma in upto 74% FDI is under automatic route and beyond 74% is under the government approval route.

- FDI up to 100% is allowed under the automatic route for the manufacturing of medical devices.

- 9 Biotechnology Parks

- 4 Biotechnology Science Clusters

- 50 Bio-incubators

- 22% Expected CAGR (2016-22)

- HBV World's largest producer of recombinant Hepatitis B vaccine

- BT Cotton World's largest producer of BT Cotton

- Plants World's highest number of USFDA approved plants

Industry Scenario
The Indian Biotechnology industry that was valued at $62 bn in 2019 will reach $150 bn target by 2025.
The sector is divided into five major segments: Bio-Pharmaceuticals, Bio-Services, Bio-Agriculture, Bio-Industrial, and Bio-IT.

The percentage share of the biotechnology segments is:

Bio-Pharmaceuticals: 64%
Bio-Services: 18%
Bio-Industrial: 3%
Bio-IT: 1%
India is also one of the first countries to have a department dedicated to Biotechnology. Moreover, the Department has also set up BIRAC (Biotechnology Industry Research Assistance Council) which is a not-for-profit agency to strengthen and empower emerging Biotechnology enterprises to undertake strategic research and innovation, by handholding them from ideation to the commercialization of their products/ technologies.

GROWTH DRIVERS
Growing population
India to become the world’s most populous country by 2027

Rising public health expenditure
Government expenditure on healthcare up to 1.6% in FY20 from 1.3% in FY16, with a target of 2.5% of the country's GDP by 2025

Capacity building initiatives
Bolstered by the ‘National Biopharma Mission’, an Industry-Academia mission to skill the workforce

Cost competitive manufacturing
Hon’ble PM Narendra Modi, during 107th Indian Science Congress in January 2020, announced that the Centre aims to develop India as a world-class $100 bn Bio-manufacturing hub by 2024

Government acting as an enabler to improve EoDB
Critical Policy initiatives and support to innovative research, human resource development and entrepreneurial ecosystem by Government of India in consideration

Story Input

https://www.investindia.gov.in/sector/biotechnology 

Tags : #IndianBiotechnologySector #failsafeinvestmentoptionsinpharma #IndianPharmaInvesting #BasicsofPharmaInvesting #GreenfieldPharma #Productivitylinkedincentive

About the Author


Team Medicircle

Related Stories

Loading Please wait...
-Advertisements-


Trending Now

Are You Struggling with “Maskne”? Find the Top 5 Solutions to deal with it. March 03, 2021
Exercise could well mimic the effects of Polypill , also it's cheaper and without side effectsMarch 03, 2021
Sorrento receives USFDA clearance to start a clinical trial of Anti-CD47 antibodyMarch 03, 2021
Regular breast checks by trained health workers linked to fewer breast cancer deaths in IndiaMarch 03, 2021
Treat Doctors as Friends and Have an Open Chat with Them says Dr. Shailaja Sabnis, Consultant Physician and Rheumatologist March 03, 2021
PM Jan Aushadhi Kendra inaugurated at District Hospital, KargilMarch 02, 2021
Maharashtra records 6,397 new cases of coronavirus todayMarch 02, 2021
One in four people will have hearing problems by 2050: WHOMarch 02, 2021
6 states show surge in Covid-19 cases, India's total active cases reach 1,68,627March 02, 2021
hday for longer life ; American Heart AssociationMarch 02, 2021
Is your baby cranky due to skin complaints? Here are some quick solutions that can help you.March 02, 2021
Women Have the Right to Say “No”, says Dr. Vaishali Joshi, Senior Obstetrician & Gynaecologist, Kokilaben Ambani Hospital, MumbaiMarch 02, 2021
How to Control STDs, explains, Dr. Nikul Patel, Founder and Chief Ayurveda Consultant of Atharva Ayurveda Clinic and Panchakarma Center March 02, 2021
Registration for next phase of COVID19 Vaccination on Co-WIN2.0 portal will open at 9:00 am on 1st MarchMarch 01, 2021
Union Minister Dr. Harsh Vardhan inaugurated major healthcare projects in Imphal yesterdayMarch 01, 2021
AMRI joins network of approved manufacturers of Lipid Excipients for Pfizer-BioNTech COVID-19 VaccineMarch 01, 2021
Nationwide COVID-19 vaccination drive to cover senior citizens & people with comorbidities begins todayMarch 01, 2021
Johnson & Johnson's Covid-19 vaccine gets emergency use authorization from FDAMarch 01, 2021
“Living with Rheumatoid Arthritis” - Myth Debunked by the Expert Rheumatologist, Dr. Naga PrabhuMarch 01, 2021
Good Sexual Health is Extremely Important for Overall Health of an Individual, says Dr. Vilvapathy Karthikeyan, Consultant AndrologistMarch 01, 2021